Hydroxykynureninuria
|
0.710 |
Biomarker
|
phenotype |
GENOMICS_ENGLAND |
NAD Deficiency, Congenital Malformations, and Niacin Supplementation.
|
28792876 |
2017 |
Hydroxykynureninuria
|
0.710 |
GeneticVariation
|
phenotype |
UNIPROT |
NAD Deficiency, Congenital Malformations, and Niacin Supplementation.
|
28792876 |
2017 |
Hydroxykynureninuria
|
0.710 |
GeneticVariation
|
phenotype |
UNIPROT |
This is the first report linking xanthurenic aciduria to a mutation in the gene encoding kynureninase.
|
17334708 |
2007 |
Hydroxykynureninuria
|
0.710 |
GermlineCausalMutation
|
phenotype |
ORPHANET |
This is the first report linking xanthurenic aciduria to a mutation in the gene encoding kynureninase.
|
17334708 |
2007 |
Hydroxykynureninuria
|
0.710 |
Biomarker
|
phenotype |
CTD_human |
This is the first report linking xanthurenic aciduria to a mutation in the gene encoding kynureninase.
|
17334708 |
2007 |
Hydroxykynureninuria
|
0.710 |
GeneticVariation
|
phenotype |
BEFREE |
This is the first report linking xanthurenic aciduria to a mutation in the gene encoding kynureninase.
|
17334708 |
2007 |
Hydroxykynureninuria
|
0.710 |
CausalMutation
|
phenotype |
CLINVAR |
|
|
|
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 2
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
NAD Deficiency, Congenital Malformations, and Niacin Supplementation.
|
28792876 |
2017 |
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 2
|
0.600 |
GermlineCausalMutation
|
disease |
ORPHANET |
NAD Deficiency, Congenital Malformations, and Niacin Supplementation.
|
28792876 |
2017 |
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 2
|
0.600 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Major Depressive Disorder
|
0.310 |
Biomarker
|
disease |
BEFREE |
Here we examined circulating concentrations of inflammatory cytokines (IFN-γ, TNF-α, IL-1β, IL-6), and the acute phase protein CRP alongside plasma tryptophan, kynurenine, kynurenic acid (KYNA) and 3-hydroxyanthranilic acid (3-HAA) concentrations, and whole blood mRNA expression of IDO, kynurenine aminotransferases (KAT I and II), kynurenine-3-monooxygenase (KMO), kynureninase and SERT in patients with major depressive disorder (MDD) compared with age and sex-matched controls.
|
22683764 |
2012 |
Multiple congenital anomalies
|
0.300 |
Biomarker
|
group |
GENOMICS_ENGLAND |
NAD Deficiency, Congenital Malformations, and Niacin Supplementation.
|
28792876 |
2017 |
Congenital malformation syndrome
|
0.300 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
NAD Deficiency, Congenital Malformations, and Niacin Supplementation.
|
28792876 |
2017 |
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1
|
0.300 |
GermlineCausalMutation
|
disease |
ORPHANET |
NAD Deficiency, Congenital Malformations, and Niacin Supplementation.
|
28792876 |
2017 |
Liver Cirrhosis, Experimental
|
0.300 |
Biomarker
|
disease |
CTD_human |
Systems level analysis and identification of pathways and networks associated with liver fibrosis.
|
25380136 |
2014 |
Inflammation
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Gene expression changes by amyloid beta peptide-stimulated human postmortem brain microglia identify activation of multiple inflammatory processes.
|
16365156 |
2006 |
Degenerative Diseases, Central Nervous System
|
0.300 |
Biomarker
|
group |
CTD_human |
Gene expression changes by amyloid beta peptide-stimulated human postmortem brain microglia identify activation of multiple inflammatory processes.
|
16365156 |
2006 |
Neurodegenerative Disorders
|
0.300 |
Biomarker
|
group |
CTD_human |
Gene expression changes by amyloid beta peptide-stimulated human postmortem brain microglia identify activation of multiple inflammatory processes.
|
16365156 |
2006 |
Degenerative Diseases, Spinal Cord
|
0.300 |
Biomarker
|
group |
CTD_human |
Gene expression changes by amyloid beta peptide-stimulated human postmortem brain microglia identify activation of multiple inflammatory processes.
|
16365156 |
2006 |
Hypertensive disease
|
0.210 |
GeneticVariation
|
group |
BEFREE |
After having found no association with common polymorphisms, this study aimed to assess the role of 1 rare variant of KYNU, Arg188Gln, and kynureninase activity in relation to hypertension.
|
22012986 |
2011 |
Hypertensive disease
|
0.210 |
Biomarker
|
group |
RGD |
Kynureninase is a novel candidate gene for hypertension in spontaneously hypertensive rats.
|
11924719 |
2002 |
Blood Protein Measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genome and epigenome wide studies of neurological protein biomarkers in the Lothian Birth Cohort 1936.
|
31320639 |
2019 |
Blood Protein Measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Co-regulatory networks of human serum proteins link genetics to disease.
|
30072576 |
2018 |
Blood Protein Measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genomic atlas of the human plasma proteome.
|
29875488 |
2018 |
Congenital clubfoot
|
0.100 |
CausalMutation
|
disease |
CLINVAR |
NAD Deficiency, Congenital Malformations, and Niacin Supplementation.
|
28792876 |
2017 |